Population Council – TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement Post author:GHIAA Admin Post published:March 27, 2024 Post category: Continue ReadingPopulation Council – TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement
MPP (C-TAP) – Biotech Africa, COVID-19 Diagnostic, Patent & Material Sublicense Agreement Post author:GHIAA Admin Post published:January 25, 2024 Post category: Continue ReadingMPP (C-TAP) – Biotech Africa, COVID-19 Diagnostic, Patent & Material Sublicense Agreement
Medigen – MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement Post author:GHIAA Admin Post published:October 10, 2023 Post category: Continue ReadingMedigen – MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement
Gilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement Post author:GHIAA Admin Post published:September 28, 2022 Post category: Continue ReadingGilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement
Gilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement Post author:GHIAA Admin Post published:September 27, 2022 Post category: Continue ReadingGilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement
Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement Post author:GHIAA Admin Post published:July 25, 2022 Post category: Continue ReadingSanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
University of Washington – MPP, Long-acting Injectable HIV Treatment License Agreement Post author:GHIAA Admin Post published:January 11, 2022 Post category: Continue ReadingUniversity of Washington – MPP, Long-acting Injectable HIV Treatment License Agreement
University of Washington – MPP, Long-acting Injectable HIV Treatment License Agreement Post author:GHIAA Admin Post published:January 8, 2022 Post category: Continue ReadingUniversity of Washington – MPP, Long-acting Injectable HIV Treatment License Agreement
Merck – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:November 19, 2021 Post category: Continue ReadingMerck – MPP, Molnupiravir License Agreement